TONGLI PHARMACEUTICALS (USA), INC. Accumulated Other Comprehensive Income
TONGLI PHARMACEUTICALS (USA), INC. had Accumulated Other Comprehensive Income of $2.98 million as of 2013-12-31, per its 10-Q filed 2014-02-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2014-02-14
- 2013-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $2.98M.
- 2013-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $2.89M.
- 2013-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $2.77M.
- 2013-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $2.46M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2013-12-31 | $2.98M 10-Q · filed 2014-02-14 |
| 2013-09-30 | $2.89M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $2.77M 10-Q · filed 2013-08-19 |
| 2013-03-31 | $2.46M 10-Q · filed 2014-02-14 |
| 2012-12-31 | $2.35M 10-Q · filed 2013-02-14 |
| 2012-09-30 | $2.28M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $2.31M 10-Q/A · filed 2012-09-06 |
| 2012-03-31 | $2.08M 10-K · filed 2013-06-28 |
| 2011-12-31 | $2.29M 10-Q · filed 2012-02-14 |
| 2011-09-30 | $2.18M 10-Q · filed 2011-11-15 |
| 2011-06-30 | $1.95M 10-Q/A · filed 2011-09-02 |
| 2011-03-31 | $1.70M 10-K · filed 2012-07-16 |